Abstract Objective To evaluate the therapeutic effects of the embedding needle therapy in the preventative treatment of chronic migraine. Methods A total of 36 patients with chronic migraine were divided into an embedding needle therapy group and a flunarizine group according to random number tab...
Abstract Objective To evaluate the therapeutic effects of the embedding needle therapy in the preventative treatment of chronic migraine. Methods A total of 36 patients with chronic migraine were divided into an embedding needle therapy group and a flunarizine group according to random number table, 18 cases in each group. In the embedding needle therapy group, the thumb-tack needles were used at Sīzhúkōng (丝竹空TE 23), Hànyàn (颔厌GB 4), Wángŭ (完骨GB 12) and Cuánzhú (攒竹BL 2) and the needles were embedded for 24 h. The embedding needle therapy was given three times a week. In the flunarizine group, flunarizine was prescribed, 10 mg a day. Separately, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month (days/month) and the headache duration (hours/month) in the cases with moderate to severe headache were observed in the two groups. Results The number of days of headache attack in the cases with moderate to severe headache was reduced after treatment as compared with the number before treatment in the two groups. The headache duration was reduced obviously after treatment in the cases of moderate to severe headache in the two groups. In the 4-week follow-up, all the indexes were still reduced as compared with the indexes before treatment, indicating the significant differences in the two groups (both P < 0.05). In the embedding needle therapy group, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month was (8.1 ± 2.4) days and (7.2 ± 1.6) days separately, which were significant difference as compared with (9.7 ± 2.3) days and (8.9 ± 1.4) days in the flunarizine group (both P < 0.05). Regarding the headache duration, at the end of the 4-week treatment and in 4 weeks of the follow-up, it was (105.6 ± 10.5) h/month and (92.1 ± 7.2) h/month respectively in the embedding needle therapy group, indicating the significant differences as compared with (135.4 ± 8.9) h and (116.1 ± 8.2) h in the flunarizine group respectively (both P < 0.05). Conclusion The 4-week treatment with the embedding needle therapy obviously reduces the number of days of headache attack and the headache duration, presents the preventative effects in the patients with chronic migraine.
Abstract Objective To evaluate the therapeutic effects of the embedding needle therapy in the preventative treatment of chronic migraine. Methods A total of 36 patients with chronic migraine were divided into an embedding needle therapy group and a flunarizine group according to random number table, 18 cases in each group. In the embedding needle therapy group, the thumb-tack needles were used at Sīzhúkōng (丝竹空TE 23), Hànyàn (颔厌GB 4), Wángŭ (完骨GB 12) and Cuánzhú (攒竹BL 2) and the needles were embedded for 24 h. The embedding needle therapy was given three times a week. In the flunarizine group, flunarizine was prescribed, 10 mg a day. Separately, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month (days/month) and the headache duration (hours/month) in the cases with moderate to severe headache were observed in the two groups. Results The number of days of headache attack in the cases with moderate to severe headache was reduced after treatment as compared with the number before treatment in the two groups. The headache duration was reduced obviously after treatment in the cases of moderate to severe headache in the two groups. In the 4-week follow-up, all the indexes were still reduced as compared with the indexes before treatment, indicating the significant differences in the two groups (both P < 0.05). In the embedding needle therapy group, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month was (8.1 ± 2.4) days and (7.2 ± 1.6) days separately, which were significant difference as compared with (9.7 ± 2.3) days and (8.9 ± 1.4) days in the flunarizine group (both P < 0.05). Regarding the headache duration, at the end of the 4-week treatment and in 4 weeks of the follow-up, it was (105.6 ± 10.5) h/month and (92.1 ± 7.2) h/month respectively in the embedding needle therapy group, indicating the significant differences as compared with (135.4 ± 8.9) h and (116.1 ± 8.2) h in the flunarizine group respectively (both P < 0.05). Conclusion The 4-week treatment with the embedding needle therapy obviously reduces the number of days of headache attack and the headache duration, presents the preventative effects in the patients with chronic migraine.
Chin J Pain Med Li 17 2 65 2011 China guideline on the diagnosis and treatment of migraine
JAMA Int Med Zhao 177 4 508 2017 10.1001/jamainternmed.2016.9378 The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial
Headache Coeytaux 56 7 1238 2016 10.1111/head.12857 Role of acupuncture in the treatment or prevention of migraine, tension-type headache, or chronic headache disorders
Chin J Pain Med 22 10 721 2016 Pain branch of Chinese medical association; committee on pain and sensory disorders, neurology specialty branch of Chinese medical doctor association. China guideline on prevention of migraine
Acta Neurol Scand Lai 135 4 476 2016 10.1111/ane.12626 Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
Hunan J Trad Chin Med Shi 29 5 148 2013 Progress on the clinical research of the thumb-tack needle therapy in treatment of pain disorders
Chin Acupunct Moxib Sun 36 11 1131 2016 Acupressure combined with press needles for prevention of gastroscopy-induced nausea and vomiting
Shanghai J Acupunct Moxib Zhang 37 3 266 2018 Clinical study on intradermal needle plus acupoint application in preventing constipation after acute craniocerebral injury
BMC Neurol Vikelis 17 1 97 2017 10.1186/s12883-017-0869-3 Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
J Pain Off J Am Pain Soc Liu 18 8 1006 2017 10.1016/j.jpain.2017.03.012 Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: a randomized controlled trial
Chin J Integr Med Cardio-Cerebrovasc Dis Zhao 16 14 2007 2018 Discussion on the differentiation and treatment of migraine in traditional Chinese medicine
Eur J Neurol Karsan 25 6 811 2018 10.1111/ene.13621 Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.